glp-1 and liver Science Behind GLP 1 GIP Glucagon Receptor Agonists for Obesity Research | News & Announcements The Role of GLP1-RAs in
Description
Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.
Members of $MED's Scientific and Clinical Affairs team and Medifasts Scientific Advisory Board recently published an article in Diabetes, Obesity and Metabolism, highlighting GLP-1 discontinuation rates
Patients were considered to be on treatment for the period during which prescriptions were refilled before the estimated end date of the most recent prescription, including a 90-day grace period, i.e
Learn what determines your individual timeline and treatment strategy
It is not approved yet, but the data is starting to demand attention
